MAPK6 and lung adenocarcinoma: In addition, by analyzing the c‐Bioportal/TCGA NSCLC datasets [30], we found that high ERK3 expression level indicates poor overall survival of patients with lung adenocarcinomas (LUADs) (Fig. 1B).